Abcellera Biologics Inc (NQ: ABCL )
3.230
-0.100
(-3.00%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 14, 2024
Add to My Watchlist
Press Releases about Abcellera Biologics Inc
![](https://mms.businesswire.com/media/20230414005467/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20230406005772/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://mms.businesswire.com/media/20230404006025/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://mms.businesswire.com/media/20230320005682/en/1743164/5/RQ_Bio_logo.jpg)
![](https://mms.businesswire.com/media/20230306005767/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://mms.businesswire.com/media/20230222006058/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://mms.businesswire.com/media/20230217005378/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
AbCellera Reports Full Year 2022 Business Results
February 21, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230130005739/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://mms.businesswire.com/media/20230123005747/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20230119005918/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://mms.businesswire.com/media/20230103005877/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://mms.businesswire.com/media/20221215005196/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
AbCellera and AbbVie Partner to Advance New Antibody Therapies
December 15, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221129005911/en/1649906/5/AbCellera_Full_Colour.jpg)
![](https://mms.businesswire.com/media/20221109005958/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://mms.businesswire.com/media/20221104005576/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
AbCellera Reports Q3 2022 Business Results
November 08, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221104005586/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
AbCellera to Present at Upcoming Investor Conferences in November
November 04, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221031005802/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://mms.businesswire.com/media/20221011006080/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://mms.businesswire.com/media/20221005005054/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://mms.businesswire.com/media/20220921005283/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://mms.businesswire.com/media/20220809005427/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
AbCellera Reports Q2 2022 Business Results
August 09, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220803005076/en/1532445/4/Atlas-Logo-2015-Icon-%2B-Type.jpg)
![](https://mms.businesswire.com/media/20220722005487/en/1523913/5/Versant_Logo.jpg)
![](https://mms.businesswire.com/media/20220712005059/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://mms.businesswire.com/media/20220629005715/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://mms.businesswire.com/media/20220510005127/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
AbCellera Reports Q1 2022 Business Results
May 10, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220429005732/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://mms.businesswire.com/media/20220426005146/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://mms.businesswire.com/media/20220411005730/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
![](https://mms.businesswire.com/media/20220408005017/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg)
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.